12:00 AM
 | 
Nov 13, 2006
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Oxygent perflubron: Phase II delayed

ALLP said the German Ethics Committee rejected an appeal to start a 65-patient Phase II trial to prevent POI resulting from hypoxia during major surgery. In August, the...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >